Targeting neuroinflammation in Alzheimer’s disease
Almost 47 million people suffer from dementia worldwide, with an estimated new case diagnosed every 3.2 seconds. Alzheimer’s disease (AD) accounts for approximately 60%–80% of all dementia cases. Given this evidence, it is clear dementia represents one of the greatest global public health challenges...
Main Authors: | Bronzuoli, Maria Rosanna, Iacomino, Aniello, Steardo, Luca, Scuderi, Caterina |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098782/ |
Similar Items
-
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
by: Steardo, Luca, et al.
Published: (2015) -
Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
by: Scuderi, Caterina, et al.
Published: (2014) -
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease
by: Scuderi, C, et al.
Published: (2014) -
Neuroinflammation and Copper in Alzheimer's Disease
by: Choo, Xin Yi, et al.
Published: (2013) -
Neuroinflammation in Alzheimer’s disease
by: Zhang, Fengjin, et al.
Published: (2015)